Prognostic significance of risk stratification in CHAARTED and LATITUDE studies among Japanese men with castration-resistant prostate cancer

Prognostic significance of risk stratification in CHAARTED and LATITUDE studies among Japanese men with castration-resistant prostate cancer

Background: The CHAARTED and LATITUDE trials demonstrated a survival benefit of docetaxel and abiraterone for hormone-sensitive prostate cancer. In this study, we examined the impact of the risk stratification criteria used in the CHAARTED and LATITUDE trials on the prognosis of castration-resistant...

Full description

Bibliographic Details
Main Authors: Sotaro Chikamatsu, Masaki Shiota, Shigetomo Yamada, Leandro Blas, Takashi Matsumoto, Eiji Kashiwagi, Junichi Inokuchi, Ken-ichiro Shiga, Akira Yokomizo, Masatoshi Eto
Format: Article
Language:English
Published: Elsevier 2022-03-01
Series:Prostate International
Subjects:
Androgen-deprivation therapy
Castration-resistant prostate cancer
Docetaxel
Androgen receptor pathway inhibitor
Risk stratification
Online Access:http://www.sciencedirect.com/science/article/pii/S2287888222000010

Internet

http://www.sciencedirect.com/science/article/pii/S2287888222000010

Similar Items